Antibody-drug Conjugates Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: ImmunoGen, Inc. (NasdaqGS :IMGN), Seagen Inc. (NasdaqGS SGEN),

Registering a CAGR of 12.8% over the forecast period, the market value of Antibody-drug Conjugates is expected to reach US$ 20.40 billion in the year 2027.

Antibody-drug Conjugates Market Overview

Antibody-drug Conjugates (ADCs) are highly potent biopharmaceutical medications made by permanently or labile linking a tiny molecular therapeutic agent or anticancer drug to an antibody. ADCs are designed to deliver chemotherapeutic chemicals to cancer cells while avoiding hurting healthy cells, allowing patients to recover faster. Increasing antibody therapy research, the availability of funds to expedite ongoing drug discovery and oncology disease research, and rising healthcare spending are likely to drive global market revenue growth over the projection period.  In addition, rising number of biotechnology and pharmaceutical companies along with research centers, and increasing FDA drug approvals and preclinical research activities are other factors expected to fuel market growth between 2021 and 2028.

DCs are a class of biopharmaceutical designed for the treatment of cancer, comprising an antibody that specifically targets a tumor antigen and a cytotoxic compound connected via a chemical linker. ADCs are intended to allow the specific targeting of the cytotoxic compound to kill cancer cells while having a limited effect on healthy tissue. 

the increasing prevalence of cancer is expected to be one of the key factors driving the market over the forecast period. As per Globocan, in 2020, the incidence of cancer reached 19.3 million, and estimated deaths due to cancer were 9.96 million. The incidence is expected to reach 21.9 million by 2025 and 24.6 million by 2030. Antibody-drug conjugates (ADCs) combine the sensitive and unique targeting abilities of antibodies, which allows sensitive discrimination between cancer tissues and healthy tissues with the cell-killing ability of cytotoxic drugs.

Industry News and Updates:

Seagen and Sanofi Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates

03/16/2022 – Seagen Inc. (Nasdaq:SGEN) and Sanofi today announced an exclusive collaboration agreement to design, develop, and commercialize antibody-drug conjugates (ADCs) for up to three cancer targets. The collaboration will utilize Sanofi’s proprietary monoclonal antibody (mAb) technology and Seagen’s proprietary ADC technology. ADCs are antibodies engineered to deliver potent anti-cancer drugs to tumor cells expressing a specific protein and Sanofi currently has one ADC in development.

What are the major Applications, Types and Regions for Antibody-drug Conjugates Market?

Market is segmented based on the type, applications, companies and regions.

By Type, it is segmented into

• Adcetris


• Kadcyla


• Others

By Application, it is segmented into

• Breast Cancer


• Lymphoma


• Others

Antibody-drug Conjugates Market Regional Analysis

North America is the most COVID-influenced area across the world. Because of the flare-up of COVID-19, the market is expected to face slight difficulty in attributing to the postponement in diagnosis, drug deficiencies, and others. The antibody drug conjugate market in North America is exceptionally competitive due to the presence of an enormous level of market players.

North America is expected to control the worldwide market rapidly because of the expanding multiplication of technologically innovative technologies in the countries of the region such as the United States, Canada, and Mexico. North America is a very developed region as far as clinical information, and the utilization of ADCs is considered and makes up the vast majority of the established market. For instance, in April 2021, Pfizer acquired Amplyx Pharmaceuticals Inc. to develop antibody drug conjugates and several other therapies for cancer. Moreover, Asia Pacific is expected to contribute significantly to the market growth during the forecast time because of the COVID-19 flare in Wuhan Province in China and further adjoining nations.

• North America
  
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East & Africa
  
  
  • Latin America
  
  
  
  

The Antibody-drug Conjugates Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Antibody-drug Conjugates Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

What is our Antibody-drug Conjugates Market report scope?

Scope of the Report covers Antibody-drug Conjugates Market with detailed analysis of the overall scenario for the market. It also highlights the business participants environment in the global marketplace. This report also provides an overview of leading companies covering the latest successful marketing strategies, market contributions, current and historical background and latest market happenings to help key organizations to grow and generate larger profits. Business players will greatly benefit from this Antibody-drug Conjugates Market analysis report as it has vital details to provide about regional markets, expected opportunities for the prediction time period 2022-2027. Growth between segments is used to understand the different growth factors that are expected to dominate the market as a whole and to develop strategies to differentiate between key applications and target markets. It further reveals how worldwide market is working through efficient information graphics.

Key Takeaways from this Antibody-drug Conjugates Report

• Evaluate Antibody-drug Conjugates market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.


• Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.


• Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.


• Analyze the sales and distribution channels across geographies to enhance top-line revenues.


• Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.


• Get a quick outlook on the Antibody-drug Conjugates market entropy - M&A's, deals, partnerships, product launches of all key players for the past 5 years.


• Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.

All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.

Frequently Asked Questions

What is the study period of this market?

The Antibody-drug Conjugates Market is studied from 2017 - 2027.

Who are the key players in Antibody-drug Conjugates Market?

ImmunoGen, Inc. (NasdaqGS :IMGN), Seagen Inc. (NasdaqGS SGEN), Roche, Takeda Pharmaceutical Company Ltd., F. Hoffmann-La Roche Ltd., Pfizer, Inc., AstraZeneca, Gilead Sciences, Inc., Astellas Pharma, Seagen, Inc., Daiichi Sankyo Company Ltd., GlaxoSmithKline Plc, ADC Therapeutics and others.

What are the significant types of Antibody-drug Conjugates Market?

Adcetris, Kadcyla, Others.

What are the major end-use applications of Antibody-drug Conjugates Market?

Breast Cancer, Lymphoma, Others.

What segments are covered in the Antibody-drug Conjugates Market report?

The Global Antibody-drug Conjugates Market is segmented on the basis of Product, Application, and Geography.

How can I get a sample report/company profile for the Antibody-drug Conjugates Market?

The sample report for the Antibody-drug Conjugates Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.